Background Information

Participants compare their normal (i.e., check) variety to newer registered varieties. Growers were encouraged to grow the newly registered flax variety, CDC Esme.
Management practices at each site were consistent across all treatments and with remainder of the field for all practices other than variety.

Summary

Site FV01 did exhibit yield data that proved statistically significant differences between the two varieties. The statistics and full set of data reveal that there is statistical difference between the varieties across four reps, and CDC Esme out-yielded CDC Rowland in each of them. When broken down further, in this site and in 2025 conditions, Esme would narrowly out-yield Rowland 96 per cent of the time.

Site FV02 did not exhibit statistically significant data, though the results show an average four-bushel yield increase in CDC Esme versus NuLin 50. The reason for this is that there was greater variability between trial replicates, making it more difficult to determine if yield differences are a result of varietal traits or external factors. Regardless, confidence was still quite good in this site year, and trial statistics determined that Esme will out-yield NuLin 50 at least nine out of 10 times in this site.